These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
506 related items for PubMed ID: 18930647
1. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol. Blais L, Beauchesne MF, Forget A. Respir Med; 2009 Feb; 103(2):237-43. PubMed ID: 18930647 [Abstract] [Full Text] [Related]
2. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence. Blais L, Forget A, Ramachandran S. Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680 [Abstract] [Full Text] [Related]
4. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma. O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M. J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333 [Abstract] [Full Text] [Related]
6. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study. Vogelmeier C, Naya I, Ekelund J. Clin Drug Investig; 2012 Jul 01; 32(7):439-49. PubMed ID: 22607479 [Abstract] [Full Text] [Related]
8. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis. Tunceli O, Williams SA, Kern DM, Elhefni H, Pethick N, Wessman C, Zhou S, Trudo F. J Allergy Clin Immunol Pract; 2014 Jul 01; 2(6):719-26. PubMed ID: 25439363 [Abstract] [Full Text] [Related]
9. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M. J Allergy Clin Immunol; 2008 Jun 01; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221 [Abstract] [Full Text] [Related]
13. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. Frois C, Wu EQ, Ray S, Colice GL. Clin Ther; 2009 Dec 01; 31(12):2779-803. PubMed ID: 20110019 [Abstract] [Full Text] [Related]
14. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma. Akamatsu T, Shirai T, Kato M, Yasui H, Hashimoto D, Fujisawa T, Tsuchiya T, Inui N, Suda T, Chida K. Pulm Pharmacol Ther; 2014 Feb 01; 27(1):52-6. PubMed ID: 23583566 [Abstract] [Full Text] [Related]
19. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers. Palmqvist M, Arvidsson P, Beckman O, Peterson S, Lötvall J. Pulm Pharmacol Ther; 2001 Feb 01; 14(1):29-34. PubMed ID: 11162416 [Abstract] [Full Text] [Related]
20. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. van der Woude HJ, Boorsma M, Bergqvist PB, Winter TH, Aalbers R. Pulm Pharmacol Ther; 2004 Feb 01; 17(2):89-95. PubMed ID: 15123230 [Abstract] [Full Text] [Related] Page: [Next] [New Search]